On Air
Krater 96
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
By Shannon Liao, CNN Business Leading Covid-19 vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion for $39 billion.
- SUBSCRIBE :
More Episodes
- Posted
Actress Christina Ricci has been granted a restraining order against her estranged husband, James Heerdegen, whom she is accusing…
- Posted
Netflix announced on Thursday that Bridgerton is officially coming back for season 2. The series, based on a series of…
- Posted
By Annie Grayer, CNN US Capitol Police are investigating an incident in which a Republican lawmaker was stopped from…
- Posted
By Caroline Kelly, CNN The Justice Department inspector general is investigating the sudden departure of former Atlanta US Attorney…